TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
1-Year Return
18.15%
This Quarter Return
-1.41%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.59B
AUM Growth
-$205M
(-7.3%)
Cap. Flow
-$97.3M
Cap. Flow
% of AUM
-3.75%
Top 10 Holdings %
Top 10 Hldgs %
43.13%
Holding
169
New
17
Increased
28
Reduced
45
Closed
8
Top Buys
| 1 |
Amgen
AMGN
|
$42.1M |
| 2 |
AbbVie
ABBV
|
$23.4M |
| 3 |
Bristol-Myers Squibb
BMY
|
$21.4M |
| 4 |
CELG
Celgene Corp
CELG
|
$13.2M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
$11.2M |
Top Sells
| 1 |
Abbott
ABT
|
$25.8M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
$23.6M |
| 3 |
AGN
Allergan plc
AGN
|
$21.4M |
| 4 |
Gilead Sciences
GILD
|
$20.1M |
| 5 |
Neurocrine Biosciences
NBIX
|
$18.4M |
Sector Composition
| 1 | Healthcare | 92.75% |
| 2 | Real Estate | 2.87% |
| 3 | Financials | 0.33% |
